衰弱与男性压力性尿失禁术后并发症及装置修正/移除相关
回顾性分析2014-2016年7252例接受人工尿道括约肌或男性尿道吊带术的Medicare受益人,用索赔衰弱指数(CFI)评估基线衰弱。30天并发症发生率为15%,1年内装置修正/移除率为11%。衰弱独立于年龄和合并症,与30天并发症及装置修正/移除风险增加相关。
要点
- 衰弱独立于年龄和合并症,与30天并发症风险增加相关。
- 衰弱亦与1年内装置修正/移除风险增加相关,但合并症指数无此关联。
- 术前决策应纳入衰弱评估,其重要性可能超过合并症。
核心结论
- 衰弱独立于年龄和合并症,与30天并发症及装置修正/移除风险增加相关。
- 衰弱而非合并症,是AUS或吊带术前决策中重要但常被忽视的因素。
研究设计与样本
- 回顾性研究,纳入2014至2016年接受AUS或吊带的Medicare受益人共7252例。
- 基线衰弱用索赔衰弱指数(CFI)量化:不衰弱(<0.15)、衰弱前期(0.15-0.24)、轻至重度衰弱(≥0.25)。
- 采用广义线性回归模型(对数链接、泊松分布、稳健标准误)分析30天并发症和装置修正/移除。
主要发现
- 30天并发症发生率为15%(N=1052),1年内装置修正/移除率为11%(N=841)。
- 30天并发症与CFI升高相关:衰弱前期aRR 1.5,轻至重度衰弱aRR 2.5(以不衰弱为参照,全局P=.0001)。
- 装置修正/移除与CFI升高相关:衰弱前期aRR 1.2,轻至重度衰弱aRR 1.3(以不衰弱为参照,全局P=.04)。
- 30天并发症与年龄相关:75-84岁aRR 1.2,≥85岁aRR 1.4(以66-74岁为参照,全局P=.0007)。
- 装置修正/移除与年龄相关:75-84岁aRR 1.3,≥85岁aRR 1.5(以66-74岁为参照,全局P=.0002)。
关键数值与推荐
- CFI分类阈值:不衰弱<0.15,衰弱前期0.15-0.24,轻至重度衰弱≥0.25。
- 30天并发症与Charlson合并症指数相关:1-3分aRR 1.2,≥4分aRR 1.8(以0分为参照,全局P=.0001)。
- 装置修正/移除与Charlson合并症指数无关(全局P=.2)。
临床怎么用
- 对拟行AUS或男性尿道吊带术的患者,术前应评估衰弱状态以辅助风险分层和决策。
- 衰弱评估可识别独立于年龄和合并症的高并发症及装置修正/移除风险人群。
局限性
- 回顾性研究设计,基于Medicare索赔数据,可能存在编码偏倚和未测量混杂。
- 仅纳入Medicare受益人,结果外推至其他人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Our goal was to understand the association between frailty and postoperative complications after artificial urinary sphincter (AUS) and male urethral sling placement. MATERIALS AND METHODS: This was a retrospective study of Medicare beneficiaries undergoing AUS or sling from 2014 to 2016. Baseline frailty was quantified using the Claims-Based Frailty Index (CFI): not frail (<0.15), prefrail (0.15-0.24), and mildly-to-severely frail (≥0.25). Thirty-day complications and device revision/removal were analyzed using generalized linear regression models with log link, Poisson distribution, and robust standard errors. RESULTS: Altogether, 7252 men underwent surgery: 62.2% AUS and 37.8% sling. Mean age was 74.2 years (SD 5.6 years), and mean CFI was 0.15 (SD 0.05). Thirty-day complications occurred in 15% (N = 1052), and device revision/removal within 1 year occurred in 11% (N = 841). Thirty-day complications were associated with increasing CFI (prefrail adjusted relative risk [aRR] 1.5, mildly-to-severely frail aRR 2.5, compared with not frail, global P = .0001), age (75-84 aRR 1.2, ≥85 aRR 1.4, compared with 66-74, global P = .0007), and Charlson Comorbidity Index (1-3 aRR 1.2, ≥4 aRR 1.8, compared with 0, global P = .0001). Device revision/removal was associated with increasing CFI (prefrail aRR 1.2, mildly-to-severely frail aRR 1.3, compared with not frail global P = .04) and age (75-84 aRR 1.3, ≥85 aRR 1.5, compared with 66-74, global P = .0002), but not Charlson Comorbidity Index (global P = .2). CONCLUSIONS: Frailty, independent of age and comorbidity, was associated with increased odds of 30-day complications and device revision/removal. Thus, frailty, more than comorbidity, is an important yet often unrecognized factor that should be considered during preoperative decision-making for AUS or sling procedures.
引用
- Nik-Ahd F, Dreyfuss LD, Wang L, et al. Frailty Is Associated With Postoperative Complications and Device Removal and Revision in Men Undergoing Surgery for Stress Urinary Incontinence. J Urol. 2026. PMID: 42456160. doi:10.1097/JU.0000000000005102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。